The FDA has cleared Iridex to market its TxCell system for laser delivery. The technology, which allows for the laser to be administered in a multi-spot scanning fashion, is intended to cut the time it takes for doctors to perform various laser photocoagulation procedures.
Iridex lands 510(k) clearance for laser delivery device
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||